Skip to main content
Type at least 3 characters

11,488 articles

Study Protocol

Accepted on 10 Apr 2025

A multi-center, randomized, double-blind, placebo-controlled trial to evaluate the efficacy and safety of Fuzheng Yangxin Prescription in treating heart failure with preserved ejection fraction (Qi-Yin deficiency and blood stasis syndrome): Study Protocol

in Heart Failure and Transplantation

  • Jingjing Chen
  • Zian Yan
  • Jiacong Wang
  • Lijun Guo
  • Zhonghui Jiang
  • Fangfang Wang
  • Ruina Bai
  • Xiaochang Ma
Frontiers in Cardiovascular Medicine
doi 10.3389/fcvm.2025.1514181
  • 101 views